Wait, we have a special offer for you! ✋

Get your exclusive discount now

Use FY25SAVE to get flat 20% off on the report No, I'd pay the full price

Terms & Conditions : This coupon is vaild exclusively for Global Market Reports 2025 and can be used Until March 31 , 2025 .

Global Oncolytic Adenovirus Market Report 2025

Oncolytic Adenovirus Global Market Report 2025 - By Virus Type (Adenovirus Type 5-Based Oncolytic Viruses, Adenovirus Type 2-Based Oncolytic Viruses, Other Virus Types), By Application (Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Other Applications), By End-User (Hospitals, Cancer Research Institutes, Biotechnology Companies, Academic And Research Institutes) - Market Size, Trends, And Global Forecast 2025-2034

Oncolytic Adenovirus Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : March 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Oncolytic Adenovirus Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

What Is Covered Under Oncolytic Adenovirus Market?

Oncolytic adenovirus is a genetically modified virus designed to selectively infect and destroy cancer cells while sparing healthy tissue. It replicates within tumor cells, causing them to rupture and release new viral particles, which further attack the cancer. Additionally, it stimulates the immune system to enhance the body's anti-tumor response.

The main virus types of oncolytic adenoviruses are adenovirus type 5-based oncolytic viruses, adenovirus type 2-based oncolytic viruses, and other virus types. Adenovirus type 5-based oncolytic viruses are genetically modified adenoviruses designed to selectively infect and destroy cancer cells while sparing normal tissues. These are applied in treating Melanoma, Prostate Cancer, breast cancer, ovarian cancer, lung cancer, and others and are used by end-users including hospitals, cancer research institutes, biotechnology companies, and academic and research institutes.

What Is The Oncolytic Adenovirus Market Size 2025 And Growth Rate?

The oncolytic adenovirus market size has grown strongly in recent years. It will grow from $122.31 billion in 2024 to $132.87 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increased cancer prevalence, growing demand for targeted cancer therapies, rising R&D funding, improved delivery methods, and regulatory approvals.

What Is The Oncolytic Adenovirus Market Growth Forecast?

The oncolytic adenovirus market size is expected to see strong growth in the next few years. It will grow to $183.22 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to growing cancer prevalence and incidence, expansion of combination therapies, regulatory advancements and approvals, technological advancements in virus engineering, and increased investment in oncology research. Major trends in the forecast period include advancements in viral engineering techniques, advanced drug delivery systems, advancements in tumor targeting precision, advanced immunotherapy combinations, and advancements in patient monitoring and diagnostics.

Oncolytic Adenovirus Market Size and growth rate 2025 to 2029: Graph

How Is The Oncolytic Adenovirus Market Segmented?

The oncolytic adenovirus market covered in this report is segmented –

1) By Virus Type: Adenovirus Type 5-Based Oncolytic Viruses, Adenovirus Type 2-Based Oncolytic Viruses, Other Virus Types

2) By Application: Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Other Applications

3) By End-User: Hospitals, Cancer Research Institutes, Biotechnology Companies, Academic And Research Institutes

Subsegments:

1) By Adenovirus Type 5-Based Oncolytic Viruses: First-generation Adenovirus Type 5-based, Second-generation Adenovirus Type 5-based, Engineered Adenovirus Type 5-based

2) By Adenovirus Type 2-Based Oncolytic Viruses: First-generation Adenovirus Type 2-based, Second-generation Adenovirus Type 2-based, Engineered Adenovirus Type 2-based

3) By Other Virus Types: Modified Adenovirus Strains, Hybrid Adenovirus Types, Chimeric Adenoviruses

Book your 30 minutes free consultation with our research experts

Contact Us

What Is Driving The Oncolytic Adenovirus Market? Surge In Cancer Diagnoses Drives Breakthroughs In Precision Treatment Technologies

The increasing incidence of cancer is expected to propel the growth of the oncolytic adenovirus market going forward. Cancer is a disease characterized by uncontrolled cell growth and spread to other parts of the body. The increasing incidence of cancer is driven by aging populations, lifestyle factors, environmental exposures, genetic predispositions, and improved detection. Oncolytic adenovirus targets and kills cancer cells selectively, offering a promising approach to treating the increasing incidence of cancer. For instance, in May 2024, according to the reports published by the National Cancer Institute (NCI), a US-based government agency, there were nearly 20 million new cancer cases and 9.7 million deaths worldwide, with projections for 2040 rising to 29.9 million cases and 15.3 million deaths. Furthermore, in 2023, according to the Australian Bureau of Statistics, an Australia-based government agency, 1.8% of Australians had cancer, with males (2.1%) slightly more affected than females (1.6%), especially those aged 75 and over. Therefore, the increasing incidence of cancer is driving growth in the oncolytic adenovirus market.

Who Are The Major Players In The Global Oncolytic Adenovirus Market?

Major companies operating in the oncolytic adenovirus market are Amgen Inc., Targovax ASA, CG Oncology Inc., Replimune Group Inc., Imugene Limited, Oncorus Inc., PsiOxus Therapeutics Ltd., Vyriad Inc., Transgene SA, Valo Therapeutics Oy, EpicentRx Inc., DNAtrix Inc., Shanghai Sunway Biotech Co. Ltd., TILT Biotherapeutics Ltd., Oncolys BioPharma Inc., Lokon Pharma AB, GeneMedicine Co. Ltd., Akamis Bio Ltd., Genelux Corporation, SillaJen Inc.

What Are The Key Trends Of The Global Oncolytic Adenovirus Market? VCN-01 A New Frontier In Cancer Treatment With FDA Fast Track Approval

Major companies operating in the oncolytic adenovirus market are focusing on combination therapies such as VCN-01, which combines oncolytic virotherapy with chemotherapy to improve tumor targeting and enhance therapeutic outcomes. VCN-01 is an oncolytic adenovirus engineered to selectively infect and destroy cancer cells while also enhancing the effectiveness of chemotherapy. For instance, in May 2024, Theriva Biologics, a US-based clinical-stage immuno-oncology company, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to its lead candidate, VCN-01. This designation applies to VCN-01 when used in combination with gemcitabine and nab-paclitaxel for the treatment of metastatic pancreatic adenocarcinoma. VCN-01 is an oncolytic adenovirus that targets and replicates within tumor cells, helping to break down the tumor stroma, a key obstacle to effective cancer treatment.

What Are Latest Mergers And Acquisitions In The Oncolytic Adenovirus Market? Synthetic Biologics Acquires VCN Biosciences To Expand Cancer Treatment Pipeline

In March 2022, Synthetic Biologics, Inc., a US-based biotechnology company, acquired VCN Biosciences for an undisclosed amount. This acquisition enhances its pipeline with VCN's clinical-stage drug VCN-01 and preclinical drug VCN-11. Both are oncolytic adenoviruses designed to target cancers with high unmet needs. VCN Biosciences, S.L. (VCN) is a Spain-based biotechnology company focused on developing oncolytic adenoviruses for cancer therapy.

What Is The Regional Outlook For The Global Oncolytic Adenovirus Market?

North America was the largest region in the oncolytic adenovirus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncolytic adenovirus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oncolytic adenovirus market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Oncolytic Adenovirus  Market?

The oncolytic adenovirus market consists of revenues earned by entities by providing services such as virus engineering and customization, clinical trial management, regulatory consulting, and contract research services. The market value includes the value of related goods sold by the service provider or included within the service offering. The oncolytic adenovirus market also includes sales of therapies, customized viral vectors, and combination therapies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Oncolytic Adenovirus  Industry?

The oncolytic adenovirus market research report is one of a series of new reports from The Business Research Company that provides oncolytic adenovirus market statistics, including the oncolytic adenovirus industry global market size, regional shares, competitors with the oncolytic adenovirus market share, detailed oncolytic adenovirus market segments, market trends, and opportunities, and any further data you may need to thrive in the oncolytic adenovirus industry. This oncolytic adenovirus market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Oncolytic Adenovirus Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $132.87 billion
Revenue Forecast In 2034 $183.22 billion
Growth Rate CAGR of 8.4% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The oncolytic adenovirus market covered in this report is segmented –
1) By Virus Type: Adenovirus Type 5-Based Oncolytic Viruses, Adenovirus Type 2-Based Oncolytic Viruses, Other Virus Types
2) By Application: Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Other Applications
3) By End-User: Hospitals, Cancer Research Institutes, Biotechnology Companies, Academic And Research Institutes Subsegments:
1) By Adenovirus Type 5-Based Oncolytic Viruses: First-generation Adenovirus Type 5-based, Second-generation Adenovirus Type 5-based, Engineered Adenovirus Type 5-based
2) By Adenovirus Type 2-Based Oncolytic Viruses: First-generation Adenovirus Type 2-based, Second-generation Adenovirus Type 2-based, Engineered Adenovirus Type 2-based
3) By Other Virus Types: Modified Adenovirus Strains, Hybrid Adenovirus Types, Chimeric Adenoviruses
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Amgen Inc., Targovax ASA, CG Oncology Inc., Replimune Group Inc., Imugene Limited, Oncorus Inc., PsiOxus Therapeutics Ltd., Vyriad Inc., Transgene SA, Valo Therapeutics Oy, EpicentRx Inc., DNAtrix Inc., Shanghai Sunway Biotech Co. Ltd., TILT Biotherapeutics Ltd., Oncolys BioPharma Inc., Lokon Pharma AB, GeneMedicine Co. Ltd., Akamis Bio Ltd., Genelux Corporation, SillaJen Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Oncolytic Adenovirus Market Characteristics

    3. Oncolytic Adenovirus Market Trends And Strategies

    4. Oncolytic Adenovirus Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global Oncolytic Adenovirus Growth Analysis And Strategic Analysis Framework

    5.1. Global Oncolytic Adenovirus PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Oncolytic Adenovirus Market Growth Rate Analysis

    5.4. Global Oncolytic Adenovirus Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Oncolytic Adenovirus Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Oncolytic Adenovirus Total Addressable Market (TAM)

    6. Oncolytic Adenovirus Market Segmentation

    6.1. Global Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Adenovirus Type 5-Based Oncolytic Viruses

    Adenovirus Type 2-Based Oncolytic Viruses

    Other Virus Types

    6.2. Global Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Melanoma

    Prostate Cancer

    Breast Cancer

    Ovarian Cancer

    Lung Cancer

    Other Applications

    6.3. Global Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Cancer Research Institutes

    Biotechnology Companies

    Academic And Research Institutes

    6.4. Global Oncolytic Adenovirus Market, Sub-Segmentation Of Adenovirus Type 5-Based Oncolytic Viruses, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    First-generation Adenovirus Type 5-based

    Second-generation Adenovirus Type 5-based

    Engineered Adenovirus Type 5-based

    6.5. Global Oncolytic Adenovirus Market, Sub-Segmentation Of Adenovirus Type 2-Based Oncolytic Viruses, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    First-generation Adenovirus Type 2-based

    Second-generation Adenovirus Type 2-based

    Engineered Adenovirus Type 2-based

    6.6. Global Oncolytic Adenovirus Market, Sub-Segmentation Of Other Virus Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Modified Adenovirus Strains

    Hybrid Adenovirus Types

    Chimeric Adenoviruses

    7. Oncolytic Adenovirus Market Regional And Country Analysis

    7.1. Global Oncolytic Adenovirus Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Oncolytic Adenovirus Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Oncolytic Adenovirus Market

    8.1. Asia-Pacific Oncolytic Adenovirus Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Oncolytic Adenovirus Market

    9.1. China Oncolytic Adenovirus Market Overview

    9.2. China Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Oncolytic Adenovirus Market

    10.1. India Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Oncolytic Adenovirus Market

    11.1. Japan Oncolytic Adenovirus Market Overview

    11.2. Japan Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Oncolytic Adenovirus Market

    12.1. Australia Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Oncolytic Adenovirus Market

    13.1. Indonesia Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Oncolytic Adenovirus Market

    14.1. South Korea Oncolytic Adenovirus Market Overview

    14.2. South Korea Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Oncolytic Adenovirus Market

    15.1. Western Europe Oncolytic Adenovirus Market Overview

    15.2. Western Europe Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Oncolytic Adenovirus Market

    16.1. UK Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Oncolytic Adenovirus Market

    17.1. Germany Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Oncolytic Adenovirus Market

    18.1. France Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Oncolytic Adenovirus Market

    19.1. Italy Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Oncolytic Adenovirus Market

    20.1. Spain Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Oncolytic Adenovirus Market

    21.1. Eastern Europe Oncolytic Adenovirus Market Overview

    21.2. Eastern Europe Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Oncolytic Adenovirus Market

    22.1. Russia Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Oncolytic Adenovirus Market

    23.1. North America Oncolytic Adenovirus Market Overview

    23.2. North America Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Oncolytic Adenovirus Market

    24.1. USA Oncolytic Adenovirus Market Overview

    24.2. USA Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Oncolytic Adenovirus Market

    25.1. Canada Oncolytic Adenovirus Market Overview

    25.2. Canada Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Oncolytic Adenovirus Market

    26.1. South America Oncolytic Adenovirus Market Overview

    26.2. South America Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Oncolytic Adenovirus Market

    27.1. Brazil Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Oncolytic Adenovirus Market

    28.1. Middle East Oncolytic Adenovirus Market Overview

    28.2. Middle East Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Oncolytic Adenovirus Market

    29.1. Africa Oncolytic Adenovirus Market Overview

    29.2. Africa Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Oncolytic Adenovirus Market Competitive Landscape And Company Profiles

    30.1. Oncolytic Adenovirus Market Competitive Landscape

    30.2. Oncolytic Adenovirus Market Company Profiles

    30.2.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Targovax ASA Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. CG Oncology Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Replimune Group Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Imugene Limited Overview, Products and Services, Strategy and Financial Analysis

    31. Oncolytic Adenovirus Market Other Major And Innovative Companies

    31.1. Oncorus Inc.

    31.2. PsiOxus Therapeutics Ltd.

    31.3. Vyriad Inc.

    31.4. Transgene SA

    31.5. Valo Therapeutics Oy

    31.6. EpicentRx Inc.

    31.7. DNAtrix Inc.

    31.8. Shanghai Sunway Biotech Co. Ltd.

    31.9. TILT Biotherapeutics Ltd.

    31.10. Oncolys BioPharma Inc.

    31.11. Lokon Pharma AB

    31.12. GeneMedicine Co. Ltd.

    31.13. Akamis Bio Ltd.

    31.14. Genelux Corporation

    31.15. SillaJen Inc.

    32. Global Oncolytic Adenovirus Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Oncolytic Adenovirus Market

    34. Recent Developments In The Oncolytic Adenovirus Market

    35. Oncolytic Adenovirus Market High Potential Countries, Segments and Strategies

    35.1 Oncolytic Adenovirus Market In 2029 - Countries Offering Most New Opportunities

    35.2 Oncolytic Adenovirus Market In 2029 - Segments Offering Most New Opportunities

    35.3 Oncolytic Adenovirus Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Oncolytic Adenovirus Market, Sub-Segmentation Of Adenovirus Type 5-Based Oncolytic Viruses, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Oncolytic Adenovirus Market, Sub-Segmentation Of Adenovirus Type 2-Based Oncolytic Viruses, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Oncolytic Adenovirus Market, Sub-Segmentation Of Other Virus Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Oncolytic Adenovirus Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Oncolytic Adenovirus Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Amgen Inc. Financial Performance
  • Table 78: Targovax ASA Financial Performance
  • Table 79: CG Oncology Inc. Financial Performance
  • Table 80: Replimune Group Inc. Financial Performance
  • Table 81: Imugene Limited Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Oncolytic Adenovirus Market, Sub-Segmentation Of Adenovirus Type 5-Based Oncolytic Viruses, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Oncolytic Adenovirus Market, Sub-Segmentation Of Adenovirus Type 2-Based Oncolytic Viruses, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Oncolytic Adenovirus Market, Sub-Segmentation Of Other Virus Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Oncolytic Adenovirus Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Oncolytic Adenovirus Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Oncolytic Adenovirus Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Oncolytic Adenovirus Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Oncolytic Adenovirus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Amgen Inc. Financial Performance
  • Figure 78: Targovax ASA Financial Performance
  • Figure 79: CG Oncology Inc. Financial Performance
  • Figure 80: Replimune Group Inc. Financial Performance
  • Figure 81: Imugene Limited Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

Read More

How Will The Nuclear Medicine Market Grow In 2022?

Read More

What Is The Pediatric Imaging Market Overview In 2022?

Read More

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the clinical chemistry market market research report 2022 with industry size, share, segments and market growth

Read More

Virus Filtration Global Market Report 2025 – By Type( Kits And Reagents, Services, Filtration Systems, Other Types), By Application( Medical Devices, Water Purification, Air Purification, Biologicals, Vaccines And Therapeutics, Blood And Blood Products, Cellular And Gene Therapy Products, Other Applications), By End-User( Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Medical Device Companies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Herpes Simplex Virus Treatment Global Market Report 2025 – By Type (Herpes Simplex Virus-1 Infection, Herpes Simplex Virus-2 Infection), By Drug Type (Acyclovir, Valacyclovir, Famciclovir, Other Drugs), By Route Of Administration (Oral, Injection, Topical), By Vaccine (Simplirix, Other Vaccines), By Distribution Channel (Hospital Pharmacies, Drug store, Retail Pharmacies, Online Providers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Human Papillomavirus (HPV) Vaccine Global Market Report 2025 – By Type (Tetravalent, Nonavalent, Bivalent), By Disease Indication (Cervical Cancer, Anal Cancer, Vulvar And Vaginal Cancer, Penile Cancer, Oropharyngeal Cancer, Other Indications), By Distribution Channel (Hospital And Retail Pharmacies, Government Suppliers, Other Channels), By Industry Vertical (Public And Private Alliance, Government Entities, Physicians, Other Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Oncolytic Virus Therapy Global Market Report 2025 – By Therapy Type (HSV-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, NDV (Newcastle Disease Virus), Other Therapy Types), By Virus Type (Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses), By Application (Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Brain Tumor, Blood Cancer), By End-User (Hospitals, Specialty Clinics, Cancer Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Respiratory Syncytial Virus (RSV) Therapeutics Global Market Report 2025 – By Drug (Palivizumab, Ribavirin, Other Drugs), By Treatment (Immune Prophylaxis, Supportive Care, Antiviral Medications), By Dosage Form (Oral, Injectable, Other Dosage Forms), By Patient Type (Pediatrics, Adults), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Hepatitis B Virus (HBV) Global Market Report 2025 – By Type (Acute, Chronic), By Treatment (Immune Modulator Drugs, Antiviral Drugs, Vaccine, Surgery), By Age Group (Pediatrics, Adults, Seniors), By End User (Medical Providers, Patients, Healthcare Payers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Rotavirus Prophylaxis Global Market Report 2025 – By Treatment (Rotarix, Rotavac, Rotavin-M1, Oral Rehydration Fluid, Other Treatments), By Route of Administration (Oral, Parenteral, Other Route of Administrations), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels), By End-Users (Hospitals, Specialty Clinics, Homecare, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Antivirus Software Global Market Report 2025 – By Type (Computers, Tablets, Smart Phones, Other Types), By Operating System (Windows, MAC, Android Or IOS Or Linux), By End User (Corporate, Personal, Government) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Oncolytic Adenovirus market?

Oncolytic adenovirus is a genetically modified virus designed to selectively infect and destroy cancer cells while sparing healthy tissue. It replicates within tumor cells, causing them to rupture and release new viral particles, which further attack the cancer. Additionally, it stimulates the immune system to enhance the body's anti-tumor response. For further insights on the Oncolytic Adenovirus market, request a sample here

How will the Oncolytic Adenovirus market drivers and restraints affect the market dynamics? What forces will shape the Oncolytic Adenovirus industry going forward?

The Oncolytic Adenovirus market major growth driver - Surge In Cancer Diagnoses Drives Breakthroughs In Precision Treatment Technologies. For further insights on the Oncolytic Adenovirus market, request a sample here

What is the forecast market size or the forecast market value of the Oncolytic Adenovirus market?

The Oncolytic Adenovirus market size has grown strongly in recent years. The oncolytic adenovirus market size has grown strongly in recent years. It will grow from $122.31 billion in 2024 to $132.87 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increased cancer prevalence, growing demand for targeted cancer therapies, rising R&D funding, improved delivery methods, and regulatory approvals. The oncolytic adenovirus market size is expected to see strong growth in the next few years. It will grow to $183.22 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to growing cancer prevalence and incidence, expansion of combination therapies, regulatory advancements and approvals, technological advancements in virus engineering, and increased investment in oncology research. Major trends in the forecast period include advancements in viral engineering techniques, advanced drug delivery systems, advancements in tumor targeting precision, advanced immunotherapy combinations, and advancements in patient monitoring and diagnostics. For further insights on the Oncolytic Adenovirus market, request a sample here

How is the Oncolytic Adenovirus market segmented?

The oncolytic adenovirus market covered in this report is segmented –
1) By Virus Type: Adenovirus Type 5-Based Oncolytic Viruses, Adenovirus Type 2-Based Oncolytic Viruses, Other Virus Types
2) By Application: Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Other Applications
3) By End-User: Hospitals, Cancer Research Institutes, Biotechnology Companies, Academic And Research Institutes

Subsegments:
1) By Adenovirus Type 5-Based Oncolytic Viruses: First-generation Adenovirus Type 5-based, Second-generation Adenovirus Type 5-based, Engineered Adenovirus Type 5-based
2) By Adenovirus Type 2-Based Oncolytic Viruses: First-generation Adenovirus Type 2-based, Second-generation Adenovirus Type 2-based, Engineered Adenovirus Type 2-based
3) By Other Virus Types: Modified Adenovirus Strains, Hybrid Adenovirus Types, Chimeric Adenoviruses For further insights on the Oncolytic Adenovirus market, request a sample here

Which region has the largest share of the Oncolytic Adenovirus market? What are the other regions covered in the report?

North America was the largest region in the oncolytic adenovirus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncolytic adenovirus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Oncolytic Adenovirus market, request a sample here.

Who are the major players in the Oncolytic Adenovirus market?

Major companies operating in the oncolytic adenovirus market are Amgen Inc., Targovax ASA, CG Oncology Inc., Replimune Group Inc., Imugene Limited, Oncorus Inc., PsiOxus Therapeutics Ltd., Vyriad Inc., Transgene SA, Valo Therapeutics Oy, EpicentRx Inc., DNAtrix Inc., Shanghai Sunway Biotech Co. Ltd., TILT Biotherapeutics Ltd., Oncolys BioPharma Inc., Lokon Pharma AB, GeneMedicine Co. Ltd., Akamis Bio Ltd., Genelux Corporation, SillaJen Inc. . For further insights on the Oncolytic Adenovirus market, request a sample here.

What are the key trends in the Oncolytic Adenovirus market?

Major trends in the Oncolytic Adenovirus market include VCN-01 A New Frontier In Cancer Treatment With FDA Fast Track Approval. For further insights on the Oncolytic Adenovirus market, request a sample here.

What are the major opportunities in the Oncolytic Adenovirus market? What are the strategies for the Oncolytic Adenovirus market?

For detailed insights on the major opportunities and strategies in the Oncolytic Adenovirus market, request a sample here.

How does the Oncolytic Adenovirus market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Oncolytic Adenovirus market growth and SWOT analysis of the Oncolytic Adenovirus industry, request a sample here.

For detailed insights on Oncolytic Adenovirus's relation to the overall economy and other similar markets,

What are the latest mergers and acquisitions in the Oncolytic Adenovirus industry? request a sample here.

For detailed insights on the mergers and acquisitions in the Oncolytic Adenovirus industry,

What are the key dynamics influencing the Oncolytic Adenovirus market growth? SWOT analysis of the Oncolytic Adenovirus market. request a sample here.